Primer: KALA BIO (KALA US) - Apr 2026
Following the pivotal failure of its lead candidate, KPI-012, KALA BIO has ceased its development and is exploring strategic options, marking a...
82 Views
No more insights
𝛼SK or SearchENTITY
KALA BIO (KALA US)
KALA BIO (KALA US)
3
Analysis
Health Care • United States
KALA BIO, Inc. operates as a clinical-stage biopharmaceutical company. The Company designs and develops proprietary drug delivery technology to penetrate mucosal tissue such as the eyes, lungs, gastrointestinal tracts, and the female reproductive systems. KALA BIO markets its products worldwide.
morex